22 results
8-K
EX-1.1
EVOK
Evoke Pharma Inc
9 Feb 24
Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 Million
5:15pm
. Notwithstanding anything to the contrary set forth herein, it is understood and agreed by the parties hereto that Section 5 of that certain engagement … other provisions of such engagement letter are hereby terminated and superseded by this Agreement.
9.6 Binding Effect. This Agreement shall inure
8-K
EX-10.1
hsbpr
11 May 23
Departure of Directors or Certain Officers
4:00pm
424B5
a79brph qxdrlt
22 Jul 16
Prospectus supplement for primary offering
12:00am
424B5
lnusodlcbhlw y6
20 Jul 16
Prospectus supplement for primary offering
12:00am
8-K
EX-10.2
876l sz8kg8d8
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
8-K
grb 85dfuucx8hwm36
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
8-K
EX-10.1
6shpcanedm38vt jx5q9
28 May 14
Entry into a Material Definitive Agreement
12:00am